Fund Holdings — Casdin Capital, LLC

Total Portfolio Value:
$2.30B
Total Bought:
$213.22M
Total Sold:
$130.08M
Net Transaction:
+$83.14M
Notable People:
Eli D Casdin, Lawrence Jude Canzoneri, Alexandria Fisk, Angelo Crupi, Steven Michael Giordano
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Revolution Medicines, Inc.(RVMD)2,577,3332,577,3330$482.68M$529.02M23.04%+$46.34M
Relay Therapeutics, Inc.(RLAY)16,035,24016,035,2400$300.02M$289.44M12.61%-$10.58M
GeneDx Holdings Corp.CL A(WGS)3,707,1643,707,1640$254.50M$268.03M11.68%+$13.53M
Biolife Solutions Inc4,655,0004,500,000-155,000$131.46M$174.82M7.62%+$43.37M
Illumina, Inc.(ILMN)530,000530,0000$93.19M$145.05M6.32%+$51.86M
GRAIL, Inc.(GRAL)480,000680,000+200,000$32.77M$95.28M4.15%+$62.51M
10x Genomics, Inc.CL A(TXG)1,050,0001,050,0000$40.26M$94.88M4.13%+$54.62M
Standard Biotools Inc88,783,85688,783,8560$73.04M$65.75M2.86%-$7.29M
Neurogene Inc1,545,3611,585,361+40,000$48.60M$44.10M1.92%-$4.50M
Scholar Rock Holding Corporation(SRRK)665,000850,000+185,000$36.58M$41.07M1.79%+$4.50M
Personalis, Inc.(PSNL)2,550,0002,300,000-250,000$34.17M$37.44M1.63%+$3.27M
Beam Therapeutics Inc.(BEAM)1,350,0001,500,000+150,000$46.33M$36.67M1.60%-$9.66M
Tempus AI, Inc.CL A(TEM)0423,597+423,597$0$34.69M1.51%+$34.69M
Sarepta Therapeutics, Inc.(SRPT)470,0001,820,000+1,350,000$8.45M$33.16M1.44%+$24.71M
Guardant Health, Inc.(GH)185,000185,0000$27.76M$33.00M1.44%+$5.24M
Structure Therapeutics IncADS1,175,0001,030,000-145,000$63.06M$32.21M1.40%-$30.85M
Alnylam Pharmaceuticals, Inc.(ALNY)75,000120,000+45,000$22.58M$29.61M1.29%+$7.03M
Denali Therapeutics Inc.(DNLI)2,045,0001,250,000-795,000$52.60M$25.84M1.13%-$26.76M
Hims & Hers Health, Inc.CL A(HIMS)700,000800,000+100,000$24.27M$23.83M1.04%-$437.0K
Maze Therapeutics, Inc.(MAZE)843,857843,8570$25.18M$22.94M1.00%-$2.24M
Septerna, Inc.(SEPN)553,268553,2680$18.53M$21.65M0.94%+$3.12M
Parabilis Medicines Inc645,690645,6900$17.67M$20.85M0.91%+$3.18M
Adlai Nortye Group LtdADS1,250,0001,250,0000$14.38M$20.00M0.87%+$5.63M
Taysha Gene Therapies, Inc.(TSHA)3,250,0003,900,000+650,000$22.13M$18.99M0.83%-$3.14M
Agomab Therapeutics NvADS1,550,0001,550,0000$20.12M$17.20M0.75%-$2.91M
Oric Pharmaceuticals Inc01,250,000+1,250,000$0$16.84M0.73%+$16.84M
Moderna, Inc.(MRNA)75,00075,0000$5.25M$14.44M0.63%+$9.19M
Veracyte, Inc.(VCYT)276,308276,3080$16.23M$12.72M0.55%-$3.51M
Quest Diagnostics Incorporated(DGX)50,00050,0000$10.60M$11.65M0.51%+$1.06M
Biogen Inc.(BIIB)050,000+50,000$0$11.29M0.49%+$11.29M
Edgewise Therapeutics, Inc.(EWTX)0265,000+265,000$0$10.76M0.47%+$10.76M
Absci Corporation973,260973,2600$11.28M$10.48M0.46%-$798.1K
Prime Medicine, Inc.(PRME)3,167,1753,167,1750$11.69M$9.68M0.42%-$2.01M
BioNTech SEADS(BNTX)085,000+85,000$0$8.36M0.36%+$8.36M
Braveheart Bio Inc0400,000+400,000$0$8.08M0.35%+$8.08M
Rapport Therapeutics, Inc.(RAPP)0200,000+200,000$0$6.72M0.29%+$6.72M
Intellia Therapeutics, Inc.(NTLA)355,000355,0000$6.01M$4.28M0.19%-$1.73M
uniQure N.V.SHS(QURE)150,000150,0000$6.91M$3.62M0.16%-$3.29M
Century Therapeutics Inc1,228,1901,228,1900$3.01M$2.10M0.09%-$908.9K
Contineum Therapeutics IncCL A148,333148,3330$2.43M$1.99M0.09%-$440.5K
Pacific Biosciences Calif In723,767723,7670$1.22M$1.72M0.07%+$499.4K
Bridgebio Oncology Therapeut282,312282,3120$2.15M$1.16M0.05%-$993.7K
Editas Medicine Inc445,000445,0000$1.44M$1.14M0.05%-$298.1K
Monte Rosa Therapeutics Inc186,01486,014-100,000$4.50M$1.03M0.04%-$3.48M
Kardigan Inc50,00050,0000$1.19M$737.5K0.03%-$455.0K
Recursion Pharmaceuticals, Inc.CL A(RXRX)165,323165,3230$606.7K$682.8K0.03%+$76.0K
Ginkgo Bioworks Holdings IncCL A36,49336,4930$361.6K$468.2K0.02%+$106.6K
Tenaya Therapeutics Inc361,969361,9690$267.5K$218.5K0.01%-$49.0K
Disc Medicine, Inc.(IRON)65,0000-65,000$4.75M$0—-$4.75M
Sionna Therapeutics, Inc.(SION)400,0000-400,000$17.60M$0—-$17.60M
Page 1 of 1
Casdin Capital, LLC — 13F Holdings — Q3 2026 | TickerTrail